Freshpet, Inc. (FRPT) stock
Close on Nov 17, 2026Market cap $3.17BP/E 17.5Yield –
Earnings
Freshpet's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Freshpet's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 22, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026during market hours | $317.80M | +10.0% | $0.58 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026before the open | $305.60M | +15.5% | $0.39 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026before the open | $297.60M | +13.1% | $0.91 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 23, 2026before the open | $285.20M | +8.6% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 3, 2025before the open | $288.80M | +14.0% | $1.86 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 4, 2025before the open | $264.70M | +12.5% | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 5, 2025before the open | $263.20M | +17.6% | -$0.26 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025before the open | $262.70M | +22.0% | $0.36 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 4, 2024before the open | $253.40M | +26.3% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 5, 2024before the open | $235.30M | +28.4% | -$0.03 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 6, 2024before the open | $223.80M | +33.6% | $0.37 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 26, 2024before the open | $215.40M | +29.9% | $0.31 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 6, 2023before the open | $200.60M | +32.6% | -$0.15 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023before the open | $183.30M | +25.5% | -$0.35 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023before the open | $167.50M | +26.7% | -$0.52 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 27, 2023before the open | $165.80M | +43.1% | -$0.06 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 1, 2022during market hours | $151.30M | +40.6% | -$0.39 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022during market hours | $146.00M | – | -$0.45 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 2, 2022during market hours | $132.20M | – | -$0.40 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022during market hours | $115.90M | – | -$0.21 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 8, 2021during market hours | $107.60M | – | -$0.05 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 2, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 3, 2021during market hours | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 14, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 2, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Freshpet's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales growthGAAP | FY2026 | +12% – +13% | – | New | Nov 4, 2026 |
| Net sales growth | FY2026 | +10% – +12% | +8% – +11% | Raised | Aug 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $215.00M – $220.00M | – | New | Nov 4, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $210.00M – $220.00M | $205.00M – $215.00M | Raised | Aug 5, 2026 |
| capital expendituresGAAP | FY2026 | $125.00M – $150.00M | – | New | Nov 4, 2026 |
| capital expenditures | FY2026 | $150.00M | $150.00M | Reaffirmed | Aug 5, 2026 |
| Net salesGAAP | FY2027 | $1.80B | – | New | Feb 20, 2025 |
| Adjusted Gross Marginnon-GAAP | FY2027 | 49% | 48% | Raised | Nov 4, 2026 |
| Adjusted Gross Marginnon-GAAP | FY2027 | 49% | – | New | Aug 5, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2027 | 20% – 22% | 22% | Lowered | Nov 4, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2027 | 20% – 22% | – | New | Aug 5, 2026 |
| Adjusted EBITDA Marginnon-GAAP | FY2027 | 22% | – | New | Aug 4, 2025 |
Guidance vs results
The last range Freshpet gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue growth | +13% | +12.99%Σ4Q | Within range |
Guidance history
Every forecast Freshpet put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | capital expenditures | FY2026 | $125.00M – $150.00M | New |
| Nov 4, 2026 | Adjusted EBITDA | FY2026 | $215.00M – $220.00M | New |
| Nov 4, 2026 | Adjusted EBITDA margin | FY2027 | 20% – 22% | Lowered |
| Nov 4, 2026 | Adjusted Gross Margin | FY2027 | 49% | Raised |
| Nov 4, 2026 | Net sales growth | FY2026 | +12% – +13% | New |
| Aug 5, 2026 | capital expenditures | FY2026 | $150.00M | Reaffirmed |
| Aug 5, 2026 | Adjusted EBITDA | FY2026 | $210.00M – $220.00M | Raised |
| Aug 5, 2026 | Adjusted Gross Margin | FY2027 | 49% | New |
| Aug 5, 2026 | Adjusted EBITDA margin | FY2027 | 20% – 22% | New |
| Aug 5, 2026 | Net sales growth | FY2026 | +10% – +12% | Raised |
| May 6, 2026 | capital expenditures | FY2026 | $150.00M | Reaffirmed |
| May 6, 2026 | Adjusted EBITDA | FY2026 | $205.00M – $215.00M | Reaffirmed |
| May 6, 2026 | Net sales growth | FY2026 | +8% – +11% | Raised |
| Feb 23, 2026 | capital expenditures | FY2026 | $150.00M | New |
| Feb 23, 2026 | Adjusted EBITDA | FY2026 | $205.00M – $215.00M | New |
| Feb 23, 2026 | Net sales growth | FY2026 | +7% – +10% | New |
| Nov 3, 2025 | Capital expenditures | FY2025 | $140.00M | New |
| Nov 3, 2025 | Adjusted EBITDA | FY2025 | $190.00M – $195.00M | New |
| Nov 3, 2025 | Net sales growth | FY2025 | +13% | New |
| Aug 4, 2025 | Capital expenditures | FY2025 | $175.00M | Lowered |
| Aug 4, 2025 | Adjusted EBITDA | FY2025 | $190.00M – $210.00M | Reaffirmed |
| Aug 4, 2025 | Adjusted Gross Margin | FY2027 | 48% | Reaffirmed |
| Aug 4, 2025 | Adjusted EBITDA Margin | FY2027 | 22% | New |
| Aug 4, 2025 | Net sales increase | FY2025 | +13% – +16% | New |
| May 5, 2025 | Capital expenditures | FY2025 | $225.00M | Lowered |
| May 5, 2025 | Adjusted EBITDA | FY2025 | $190.00M – $210.00M | Lowered |
| May 5, 2025 | Net sales | FY2025 | $1.12B – $1.15B | New |
| Feb 20, 2025 | Capital expenditures | FY2025 | $250.00M | New |
| Feb 20, 2025 | Adjusted EBITDA | FY2025 | $210.00M | New |
| Feb 20, 2025 | Adjusted EBITDA margin | FY2027 | 22% | New |
| Feb 20, 2025 | Adjusted Gross Margin | FY2027 | 48% | New |
| Feb 20, 2025 | Net sales | FY2025 | $1.18B – $1.21B | New |
| Feb 20, 2025 | Net sales | FY2027 | $1.80B | New |
| Nov 4, 2024 | Capital expenditures | FY2024 | $180.00M | Lowered |
| Nov 4, 2024 | Adjusted EBITDA | FY2024 | $155.00M | Raised |
| Nov 4, 2024 | Net sales increase | FY2024 | +27% | New |
| Nov 4, 2024 | Net sales | FY2024 | $975.00M | New |
| Aug 5, 2024 | Capital expenditures | FY2024 | $200.00M | Lowered |
| Aug 5, 2024 | Adjusted EBITDA | FY2024 | $140.00M | Raised |
| Aug 5, 2024 | Net sales | FY2024 | $965.00M | Raised |
| May 6, 2024 | Capital expenditures | FY2024 | $210.00M | New |
| May 6, 2024 | Adjusted EBITDA | FY2024 | $120.00M | Raised |
| May 6, 2024 | Net sales | FY2024 | $950.00M | Reaffirmed |
| Feb 26, 2024 | Capital expenditures | FY2024 | $210.00M | New |
| Feb 26, 2024 | Adjusted EBITDA | FY2024 | $100.00M – $110.00M | New |
| Feb 26, 2024 | Net sales | FY2024 | $950.00M | New |
| Nov 6, 2023 | Capital expenditures | FY2023 | $240.00M | Reaffirmed |
| Nov 6, 2023 | Adjusted EBITDA | FY2023 | $62.00M | Raised |
| Nov 6, 2023 | Net sales | FY2023 | $755.00M | Raised |
| Aug 7, 2023 | Capital expenditures | FY2023 | $240.00M | Reaffirmed |
| Aug 7, 2023 | Adjusted EBITDA | FY2023 | $55.00M | Raised |
| Aug 7, 2023 | Net sales | FY2023 | $750.00M | Reaffirmed |
| May 8, 2023 | Capital expenditures | FY2023 | $240.00M | Raised |
| May 8, 2023 | Adjusted EBITDA | FY2023 | $50.00M | Reaffirmed |
| May 8, 2023 | Net sales | FY2023 | $750.00M | Reaffirmed |
| Feb 27, 2023 | Capital expenditures | FY2023 | $240.00M | New |
| Feb 27, 2023 | Adjusted EBITDA | FY2023 | $50.00M | New |
| Feb 27, 2023 | Net sales | FY2023 | $750.00M | New |
| Nov 1, 2022 | Capital expenditures | FY2022 | $290.00M | New |
| Nov 1, 2022 | capital expenditure | FY2023 | $230.00M | New |
| Nov 1, 2022 | Adjusted EBITDA | FY2022 | $15.00M | Lowered |
| Nov 1, 2022 | Net sales | FY2022 | $575.00M | Reaffirmed |
| Aug 8, 2022 | Capital expenditures | FY2022 | $320.00M | New |
| Aug 8, 2022 | Adjusted EBITDA | FY2022 | $48.00M | Lowered |
| Aug 8, 2022 | Net sales | FY2022 | $575.00M | Reaffirmed |
| May 2, 2022 | Adjusted EBITDA | FY2022 | $55.00M | Reaffirmed |
| May 2, 2022 | Net sales | FY2022 | $575.00M | Reaffirmed |
| Feb 28, 2022 | Adjusted EBITDA | FY2022 | $55.00M | New |
| Feb 28, 2022 | Net sales | FY2022 | $575.00M | New |
| Nov 8, 2021 | Adjusted EBITDA | FY2021 | $50.00M | New |
| Nov 8, 2021 | Net sales | FY2021 | $445.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Freshpet filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?